What's Changed!

Pre-Clinical:

New Developers join Pre-Clinical phases - "InstitutPasteur/ TheraVectys" & "United Biomedical (UBI)/ c19"

Clinical:

Sanofi / Regeneron; Feinstein Institutes; REMAP-CAP global trial is now discontinued.

Univ. of College, London joins Global hospital testing (AbbVie); World Health Organization SOLIDARITY trial (studying lopinavir/ ritonavir with and without interferon beta); University of Oxford RECOVERY trial;

Phase I:

Oxford Expression Technologies joins Vaxine Pty Ltd/ Flinders University/ Oracle/ Medytox/ Sypharma for vaccine trials Adimmune Corporation - Phase I began end of August 2020

Phase I / II:

Spy Biotech signs agreement with Serum Institute of India to develop COVID-19 vaccine based on research conducted in Australia 

Phase II:

Petrovax joins CanSino Biologics/Beijing Institute of Biotechnology Canada's National Research Council no more in partnership with CanSino Biologics/Beijing Institute of Biotechnology

COVID-19 Vaccine and Treatment Tracker

CoVaTrack is the first COVID-19 Vaccine & Treatment Tracker portal for India,
featuring the latest news and updates on vaccines & treatments for Novel Coronavirus, including clinical trials to approvals.

Global Statistics What's Changed!
  • 289

    Pre-clinical

    Treatments & Vaccines not yet in human trials

  • 205

    Clinical

    Treatments & vaccines undergoing clinical research

  • 9

    Phase I

    Clinical trials with volunteer groups of less than 100

  • 14

    Phase I / II

    Simultaneous trials on small & large patient groups

  • 4

    Phase II

    Clinical trials on larger groups of more than 100

  • 1

    Phase II / III

    Simultaneous trials in large and very large groups

  • 8

    Phase III

    Vaccines in large-scale efficacy tests

  • 0

    Approved

    Approved for nation-wide sale and usage

Last updated: 1:50 PM IST, 18rd Sep 2020   |  
Source: Milken Institute & WHO

COVID-19 Vaccines Approved for Limited Use

NCT04437875
Phase III
Non-Replicating Viral Vector

Developer/Manufacturer :

Binnopharm

Researcher :

Gamaleya Research Institute

Vaccine/Treatment Type :

Non-Replicating Viral Vector

NCT04313127
Phase III
Non-Replicating Viral Vector

Developer/Manufacturer :

Cansino Biologics

Researcher :

Beijing Institute of Biotechnology / National Research Council (Canada)

Vaccine/Treatment Type :

Non-Replicating Viral Vector

NCT04352608
Phase III
Inactivated Virus

Developer/Manufacturer :

Sinovac Biotech / PT Bio Farma

Researcher :

Instituto Butantan

Vaccine/Treatment Type :

Inactivated Virus

COVID-19 Vaccines & Treatments (India)

Over 30 organizations are trying to develop a vaccine to fight COVID-19.
World Health Organization (WHO) has already approved seven vaccine candidates for India.

Pre-clinical

3

Clinical

0

Phase I

2

Phase II

1

Phase III

1

Approved

0

Vaccine Tracker

  • Developer

    Bharat Biotech International Limited

  • Researcher

    ICMR - National Institute of Virology, Pune

  • Vaccine Candidate

    CTRI/2020/07/026300

  • Phase

    Phase II / Phase I

  • Developer

    Cadila Healthcare Ltd.

  • Researcher

    Cadila Healthcare Ltd.

  • Vaccine Candidate

    CTRI/2020/07/026352

  • Phase

    Phase II / Phase I

  • Developer

    Cadila Pharmaceuticals Ltd.

  • Researcher

    CSIR

  • Vaccine Candidate

    CTRI/2020/04/024846

  • Phase

    N/A

  • Developer

    Green Signal Biopharma Ltd.

  • Researcher

    JIPMER

  • Vaccine Candidate

    CTRI/2020/04/024833

  • Phase

    N/A

  • Developer

    Haffkine Institute for Training Research & Testing

  • Researcher

    Haffkine Institute for Training Research & Testing

  • Vaccine Candidate

    CTRI/2020/05/025013

  • Phase

    Phase II

  • Developer

    Indian Immunologicals Limited

  • Researcher

    Griffith University, Australia

  • Vaccine Candidate

    Pre-Clinical

  • Phase

    N/A

  • Developer

    Mynvax

  • Researcher

    Indian Institute of Science (Bengaluru)

  • Vaccine Candidate

    Pre-Clinical

  • Phase

    N/A

  • Developer

    Panacea Biotec Limited

  • Researcher

    Refana Inc, US

  • Vaccine Candidate

    Pre-Clinical

  • Phase

    N/A

  • Developer

    Serum Institute of India

  • Researcher

    National Institute for Research in Tuberculosis

  • Vaccine Candidate

    CTRI/2020/06/025854

  • Phase

    N/A

  • Developer

    Serum institute of India & AstraZeneca

  • Researcher

    University of Oxford

  • Vaccine Candidate

    CTRI/2020/04/024749

  • Phase

    Phase III

Developer Researcher Vaccine Candidate Phase
Bharat Biotech International Limited ICMR - National Institute of Virology, Pune CTRI/2020/07/026300 Phase II / Phase I
Cadila Healthcare Ltd. Cadila Healthcare Ltd. CTRI/2020/07/026352 Phase II / Phase I
Cadila Pharmaceuticals Ltd. CSIR CTRI/2020/04/024846 N/A
Green Signal Biopharma Ltd. JIPMER CTRI/2020/04/024833 N/A
Haffkine Institute for Training Research & Testing Haffkine Institute for Training Research & Testing CTRI/2020/05/025013 Phase II
Indian Immunologicals Limited Griffith University, Australia Pre-Clinical N/A
Mynvax Indian Institute of Science (Bengaluru) Pre-Clinical N/A
Panacea Biotec Limited Refana Inc, US Pre-Clinical N/A
Serum Institute of India National Institute for Research in Tuberculosis CTRI/2020/06/025854 N/A
Serum institute of India & AstraZeneca University of Oxford CTRI/2020/04/024749 Phase III

Treatment Tracker

Andhra Pradesh
  • COVID-19 status

    Healthy

  • Outcome

    Serious Adverse Events, Antibodies

  • Treatment

    SOC, Vaccine

  • Trial Participants

    1125

Bihar
  • COVID-19 status

    Healthy

  • Outcome

    Serious Adverse Events, Antibodies

  • Treatment

    SOC, Vaccine

  • Trial Participants

    1125

Chandigarh
  • COVID-19 status

    Confirmed

  • Outcome

    Mortality, Hospitalization, Clinical Improvement Score (Any), Non-invasive Ventilation, Organ Failure or Dysfunction (SOFA)

  • Treatment

    Other, SOC

  • Trial Participants

    40

Chandigarh
  • COVID-19 status

    NA

  • Outcome

    ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Other Mild Symptoms, Adverse Events, Serious Adverse Events

  • Treatment

    Other, SOC

  • Trial Participants

    480

Chandigarh
  • COVID-19 status

    Healthy

  • Outcome

    NA

  • Treatment

    HCQ, SOC

  • Trial Participants

    325

Chandigarh
  • COVID-19 status

    NA

  • Outcome

    Serious or Seconday Infections, Adverse Events, Serious Adverse Events

  • Treatment

    Other

  • Trial Participants

    4000

Chhattisgarh
  • COVID-19 status

    Confirmed

  • Outcome

    Mortality, Hospitalization, Clinical Improvement Score (Any), Non-invasive Ventilation, Organ Failure or Dysfunction (SOFA)

  • Treatment

    Other, SOC

  • Trial Participants

    40

Delhi
  • COVID-19 status

    Confirmed Or Suspected

  • Outcome

    Hospital Discharge, Invasive Mechanical Ventilation or ECMO

  • Treatment

    Positioning

  • Trial Participants

    20

Delhi
  • COVID-19 status

    Healthy

  • Outcome

    NA

  • Treatment

    Alternative therapy, SOC

  • Trial Participants

    140

Delhi
  • COVID-19 status

    Healthy

  • Outcome

    NA

  • Treatment

    Alternative therapy, SOC

  • Trial Participants

    50000

Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    ICU Admission, Hospital Discharge, Clinical Improvement Score (Any)

  • Treatment

    Plasma based therapy, SOC

  • Trial Participants

    400

Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    Mortality

  • Treatment

    Alternative therapy, SOC

  • Trial Participants

    100

Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    NA

  • Treatment

    Radiation therapy

  • Trial Participants

    10

Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    NA

  • Treatment

    Alternative therapy

  • Trial Participants

    50

Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    Mortality, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Fever, Dyspnea, Other Mild Symptoms, Organ Failure or Dysfunction (SOFA), Adverse Events, PaO2-FiO2

  • Treatment

    Plasma based therapy, SOC

  • Trial Participants

    100

Delhi
  • COVID-19 status

    Yes

  • Outcome

    Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), PaO2-FiO2

  • Treatment

    Plasma based therapy, SOC

  • Trial Participants

    29

Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    Viral Load or Clearance

  • Treatment

    Ivermectin, SOC

  • Trial Participants

    50

Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    Mortality, Pneumonia or ARDS, PaO2-FiO2

  • Treatment

    Plasma based therapy, SOC

  • Trial Participants

    452

Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    Mortality, Hospitalization, Clinical Improvement Score (Any), Non-invasive Ventilation, Organ Failure or Dysfunction (SOFA)

  • Treatment

    Other, SOC

  • Trial Participants

    40

Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    Mortality, Pneumonia or ARDS, PaO2-FiO2

  • Treatment

    Plasma based therapy, SOC

  • Trial Participants

    100

Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    Mortality

  • Treatment

    Alternative therapy, SOC

  • Trial Participants

    300

Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    NA

  • Treatment

    Alternative therapy

  • Trial Participants

    40

Delhi
  • COVID-19 status

    Healthy

  • Outcome

    NA

  • Treatment

    Alternative therapy, SOC

  • Trial Participants

    200

Delhi
  • COVID-19 status

    Suspected

  • Outcome

    NA

  • Treatment

    Alternative therapy

  • Trial Participants

    10000

Delhi
  • COVID-19 status

    Healthy

  • Outcome

    NA

  • Treatment

    Alternative therapy, SOC

  • Trial Participants

    40000

Delhi
  • COVID-19 status

    Healthy

  • Outcome

    NA

  • Treatment

    Exercise + Alternative therapy, SOC

  • Trial Participants

    452

Delhi
  • COVID-19 status

    Healthy

  • Outcome

    Serious Adverse Events, Antibodies

  • Treatment

    SOC, Vaccine

  • Trial Participants

    1125

Goa
  • COVID-19 status

    Healthy

  • Outcome

    Serious Adverse Events, Antibodies

  • Treatment

    SOC, Vaccine

  • Trial Participants

    1125

Gujarat
  • COVID-19 status

    Confirmed

  • Outcome

    Mortality, Clinical Improvement Score (Any)

  • Treatment

    Alternative therapy, SOC

  • Trial Participants

    200

Gujarat
  • COVID-19 status

    Confirmed

  • Outcome

    Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, C-Reactive Protein, Ferritin, IL-6, IL-10, Tumor Necrosis Factor (Any)

  • Treatment

    Other, SOC

  • Trial Participants

    100

Haryana
  • COVID-19 status

    Confirmed

  • Outcome

    Hospital Discharge

  • Treatment

    Alternative therapy, SOC

  • Trial Participants

    60

Haryana
  • COVID-19 status

    Confirmed

  • Outcome

    Mortality

  • Treatment

    SOC, TCZ

  • Trial Participants

    180

Haryana
  • COVID-19 status

    Healthy

  • Outcome

    Serious Adverse Events, Antibodies

  • Treatment

    SOC, Vaccine

  • Trial Participants

    1125

Karnataka
  • COVID-19 status

    Confirmed

  • Outcome

    Viral Load or Clearance, Pneumonia or ARDS, Cough, Fever, Organ Failure or Dysfunction (SOFA), Antibodies, PaO2-FiO2, SpO2, Radiographic Findings, Distress, Renal Outcome (Unspecified)

  • Treatment

    Plasma based therapy, SOC

  • Trial Participants

    24

Karnataka
  • COVID-19 status

    Healthy

  • Outcome

    Serious Adverse Events, Antibodies

  • Treatment

    SOC, Vaccine

  • Trial Participants

    1125

Madhya Pradesh
  • COVID-19 status

    Confirmed

  • Outcome

    Mortality, Hospitalization, Clinical Improvement Score (Any), Non-invasive Ventilation, Organ Failure or Dysfunction (SOFA)

  • Treatment

    Other, SOC

  • Trial Participants

    40

Maharashtra
  • COVID-19 status

    Confirmed

  • Outcome

    Hospitalization, Viral Load or Clearance, Cough, Fever, Other Mild Symptoms, Platelet Count

  • Treatment

    Alternative therapy, SOC

  • Trial Participants

    15

Maharashtra
  • COVID-19 status

    Confirmed

  • Outcome

    NA

  • Treatment

    FPV, SOC

  • Trial Participants

    156

Maharashtra
  • COVID-19 status

    Confirmed

  • Outcome

    Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, C-Reactive Protein, Ferritin, IL-6, IL-10, Tumor Necrosis Factor (Any)

  • Treatment

    Other, SOC

  • Trial Participants

    100

New Delhi
  • COVID-19 status

    Healthy

  • Outcome

    NA

  • Treatment

    SOC, Vaccine

  • Trial Participants

    1048

New Delhi
  • COVID-19 status

    Healthy

  • Outcome

    Mortality

  • Treatment

    SOC, Vaccine

  • Trial Participants

    2175

New Delhi
  • COVID-19 status

    Healthy

  • Outcome

    Cough, Other Mild Symptoms

  • Treatment

    Ivermectin

  • Trial Participants

    50

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    NA

  • Treatment

    Alternative therapy

  • Trial Participants

    30

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    NA

  • Treatment

    Alternative therapy

  • Trial Participants

    200

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    Viral Load or Clearance

  • Treatment

    Alternative therapy

  • Trial Participants

    60

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    ICU Admission, Hospital Discharge

  • Treatment

    SOC, Zinc

  • Trial Participants

    100

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    NA

  • Treatment

    Alternative therapy

  • Trial Participants

    124

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    NA

  • Treatment

    SOC, Vitamins

  • Trial Participants

    30

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    ICU Admission

  • Treatment

    Alternative therapy, SOC

  • Trial Participants

    36

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    Mortality

  • Treatment

    mAb, SOC

  • Trial Participants

    30

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    Clinical Improvement Score (Any)

  • Treatment

    Anticoagulants, SOC

  • Trial Participants

    40

New Delhi
  • COVID-19 status

    Healthy, Confirmed

  • Outcome

    Hospital Discharge

  • Treatment

    Alternative therapy, SOC

  • Trial Participants

    120

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    C-Reactive Protein, Ferritin, LDH, SpO2, Radiographic Findings

  • Treatment

    Non-invasive respiratory support, SOC

  • Trial Participants

    60

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    NA

  • Treatment

    Alternative therapy, SOC

  • Trial Participants

    140

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    Clinical Improvement Score (Any)

  • Treatment

    Alternative therapy, AZT + Vitamins + Other

  • Trial Participants

    25

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), SpO2, Shock, Distress

  • Treatment

    Alternative therapy, SOC

  • Trial Participants

    200

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    NA

  • Treatment

    Alternative therapy, HCQ

  • Trial Participants

    100

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    Fever

  • Treatment

    Alternative therapy, SOC

  • Trial Participants

    30

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    Viral Load or Clearance

  • Treatment

    Ivermectin, SOC

  • Trial Participants

    50

New Delhi
  • COVID-19 status

    Healthy, Confirmed

  • Outcome

    Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious or Seconday Infections, Serious Adverse Events, ALT

  • Treatment

    HCQ, LPV/r, SOC

  • Trial Participants

    6400

New Delhi
  • COVID-19 status

    NA

  • Outcome

    Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Other Mild Symptoms

  • Treatment

    HCQ

  • Trial Participants

    500

New Delhi
  • COVID-19 status

    Healthy (Exposed)

  • Outcome

    Cough, Fever, Dyspnea, Antibodies, Distress

  • Treatment

    SOC, Vaccine

  • Trial Participants

    1826

New Delhi
  • COVID-19 status

    Healthy

  • Outcome

    NA

  • Treatment

    Alternative therapy

  • Trial Participants

    1324

New Delhi
  • COVID-19 status

    Healthy

  • Outcome

    NA

  • Treatment

    Alternative therapy, SOC

  • Trial Participants

    1200

New Delhi
  • COVID-19 status

    Healthy

  • Outcome

    NA

  • Treatment

    Alternative therapy, SOC

  • Trial Participants

    1200

New Delhi
  • COVID-19 status

    Healthy (Exposed)

  • Outcome

    NA

  • Treatment

    HCQ, SOC

  • Trial Participants

    6950

New Delhi
  • COVID-19 status

    Healthy

  • Outcome

    NA

  • Treatment

    SOC, Vaccine

  • Trial Participants

    5946

New Delhi
  • COVID-19 status

    Healthy

  • Outcome

    NA

  • Treatment

    Alternative therapy, SOC

  • Trial Participants

    1200

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    Mortality, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO

  • Treatment

    HCQ, HCQ + AZT

  • Trial Participants

    300

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    NA

  • Treatment

    HCQ, SOC

  • Trial Participants

    60

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    ICU Admission, Hospital Discharge, Clinical Improvement Score (Any)

  • Treatment

    Plasma based therapy, SOC

  • Trial Participants

    400

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    NA

  • Treatment

    HCQ, SOC

  • Trial Participants

    166

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    Hospital Discharge, Clinical Improvement Score (Any)

  • Treatment

    Other

  • Trial Participants

    50

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    NA

  • Treatment

    Alternative therapy, SOC

  • Trial Participants

    300

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    Hospital Discharge, Viral Load or Clearance

  • Treatment

    HCQ, HCQ + Antivirals

  • Trial Participants

    158

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    NA

  • Treatment

    Corticosteroids, HCQ, Ivermectin, SOC

  • Trial Participants

    120

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    NA

  • Treatment

    Alternative therapy, SOC

  • Trial Participants

    120

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    Viral Load or Clearance

  • Treatment

    Alternative therapy, SOC

  • Trial Participants

    60

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    Invasive Mechanical Ventilation or ECMO

  • Treatment

    Plasma based therapy, SOC

  • Trial Participants

    40

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    Viral Load or Clearance

  • Treatment

    Hygiene, SOC

  • Trial Participants

    96

New Delhi
  • COVID-19 status

    Confirmed Or Suspected

  • Outcome

    Mortality

  • Treatment

    Alternative therapy

  • Trial Participants

    100

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    Cough, Fever, SpO2, Respiratory Rate

  • Treatment

    HCQ + Antivirals, LPV/r + antivirals

  • Trial Participants

    175

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    Quality of Life

  • Treatment

    Alternative therapy, SOC

  • Trial Participants

    120

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    NA

  • Treatment

    Alternative therapy, SOC

  • Trial Participants

    90

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    NA

  • Treatment

    Alternative therapy, HCQ + Vitamins + AZT + Zinc + Other

  • Trial Participants

    200

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    NA

  • Treatment

    Other, SOC

  • Trial Participants

    300

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    Viral Load or Clearance

  • Treatment

    Alternative therapy, SOC

  • Trial Participants

    60

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    Hospitalization

  • Treatment

    Alternative therapy, SOC

  • Trial Participants

    420

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    IL-6

  • Treatment

    Alternative therapy, SOC

  • Trial Participants

    10

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    NA

  • Treatment

    Alternative therapy, SOC

  • Trial Participants

    90

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    NA

  • Treatment

    Alternative therapy, SOC

  • Trial Participants

    200

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    Mortality, Hospital Discharge, Clinical Improvement Score (Any)

  • Treatment

    Alternative therapy, SOC

  • Trial Participants

    100

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    NA

  • Treatment

    IFN, SOC

  • Trial Participants

    40

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    Pneumonia or ARDS

  • Treatment

    Exercise + Nutrition + Hygiene + Alternative therapy + Other, SOC

  • Trial Participants

    658

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    Viral Load or Clearance, Cough, Fever, IL-2, IL-6, IL-10, Tumor Necrosis Factor (Any), IgG, IgM or IgA

  • Treatment

    Alternative therapy, Vitamins + Zinc

  • Trial Participants

    60

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    NA

  • Treatment

    Alternative therapy

  • Trial Participants

    40

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    Mortality, ICU Admission, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO

  • Treatment

    Alternative therapy

  • Trial Participants

    40

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    NA

  • Treatment

    Alternative therapy

  • Trial Participants

    200

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    NA

  • Treatment

    Alternative therapy

  • Trial Participants

    200

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    NA

  • Treatment

    Exercise + Alternative therapy

  • Trial Participants

    30

New Delhi
  • COVID-19 status

    Confirmed Or Suspected

  • Outcome

    NA

  • Treatment

    Alternative therapy, SOC

  • Trial Participants

    80

New Delhi
  • COVID-19 status

    Confirmed Or Suspected

  • Outcome

    NA

  • Treatment

    Alternative therapy, SOC

  • Trial Participants

    86

New Delhi
  • COVID-19 status

    Healthy

  • Outcome

    NA

  • Treatment

    Alternative therapy, SOC

  • Trial Participants

    60

New Delhi
  • COVID-19 status

    Healthy

  • Outcome

    Mortality

  • Treatment

    Vaccine

  • Trial Participants

    1450

New Delhi
  • COVID-19 status

    Suspected

  • Outcome

    Anxiety

  • Treatment

    Psychological therapy

  • Trial Participants

    128

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    Mortality

  • Treatment

    HCQ +/- AZT, HCQ + Lithium +/- AZT

  • Trial Participants

    100

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    ICU Admission, Organ Failure or Dysfunction (SOFA)

  • Treatment

    SOC, Vaccine

  • Trial Participants

    40

New Delhi
  • COVID-19 status

    Healthy, Confirmed Or Suspected

  • Outcome

    Clinical Improvement Score (Any), Quality of Life

  • Treatment

    Alternative therapy, SOC

  • Trial Participants

    500

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    NA

  • Treatment

    Alternative therapy

  • Trial Participants

    150

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    Mortality

  • Treatment

    DAA

  • Trial Participants

    50

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    NA

  • Treatment

    Alternative therapy

  • Trial Participants

    100

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    ICU Admission, Invasive Mechanical Ventilation or ECMO

  • Treatment

    Non-invasive respiratory support, SOC

  • Trial Participants

    40

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO

  • Treatment

    Other, SOC

  • Trial Participants

    300

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    Mortality, ICU Admission, Hospitalization

  • Treatment

    Radiation therapy

  • Trial Participants

    10

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    NA

  • Treatment

    Alternative therapy, SOC

  • Trial Participants

    112

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    Mortality, Hospital Discharge, Clinical Improvement Score (Any), Labor Absenteeism, Fever, SpO2, Respiratory Rate

  • Treatment

    Other, SOC

  • Trial Participants

    230

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    NA

  • Treatment

    Imatinib, SOC

  • Trial Participants

    100

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    Cough, Fever, Dyspnea, Other Mild Symptoms

  • Treatment

    Alternative therapy

  • Trial Participants

    60

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    C-Reactive Protein

  • Treatment

    Other, SOC

  • Trial Participants

    100

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    Mortality, Hospital Discharge

  • Treatment

    Plasma based therapy, SOC

  • Trial Participants

    80

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    Mortality, Clinical Improvement Score (Any)

  • Treatment

    Plasma based therapy, SOC

  • Trial Participants

    472

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    Mortality, Pneumonia or ARDS, PaO2-FiO2

  • Treatment

    Plasma based therapy, SOC

  • Trial Participants

    90

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    Mortality, Organ Failure or Dysfunction (SOFA)

  • Treatment

    Plasma based therapy, SOC

  • Trial Participants

    100

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    Mortality, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, SpO2

  • Treatment

    Positioning

  • Trial Participants

    120

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    Hospitalization

  • Treatment

    Acalabrutinib, SOC

  • Trial Participants

    30

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    Invasive Mechanical Ventilation or ECMO

  • Treatment

    Acalabrutinib, SOC

  • Trial Participants

    140

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    Pneumonia or ARDS

  • Treatment

    Plasma based therapy, SOC

  • Trial Participants

    20

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    Hospital Discharge, Clinical Improvement Score (Any)

  • Treatment

    Igs, SOC

  • Trial Participants

    100

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    Hospital Discharge, Cough, Fever, Dyspnea

  • Treatment

    Alternative therapy, SOC

  • Trial Participants

    120

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    Mortality

  • Treatment

    mAb, SOC

  • Trial Participants

    30

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    NA

  • Treatment

    FPV, SOC

  • Trial Participants

    150

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    NA

  • Treatment

    Alternative therapy

  • Trial Participants

    135

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    Clinical Improvement Score (Any)

  • Treatment

    Alternative therapy, SOC

  • Trial Participants

    200

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    Hospital Discharge, Clinical Improvement Score (Any)

  • Treatment

    Alternative therapy, SOC

  • Trial Participants

    160

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    Clinical Improvement Score (Any)

  • Treatment

    FPV, FPV + Umifenovir

  • Trial Participants

    158

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO

  • Treatment

    Other, SOC

  • Trial Participants

    300

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    Hospitalization, Hospital Discharge, Distress

  • Treatment

    SOC, Vaccine

  • Trial Participants

    60

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    Invasive Mechanical Ventilation or ECMO, PaO2-FiO2

  • Treatment

    HCQ + AZT, HCQ + Other + AZT

  • Trial Participants

    120

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO

  • Treatment

    HCQ, LPV/r, Remdesivir, SOC

  • Trial Participants

    7000

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    NA

  • Treatment

    HCQ, LPV/r, LPV/r + IFN, Remdesivir, SOC

  • Trial Participants

    10000

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    ICU Admission, Hospitalization, C-Reactive Protein

  • Treatment

    Other + Vitamins

  • Trial Participants

    210

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    NA

  • Treatment

    Alternative therapy, SOC

  • Trial Participants

    120

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    Cough, C-Reactive Protein, IgG, IgM or IgA, CD4, CD8

  • Treatment

    Alternative therapy, SOC

  • Trial Participants

    60

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    NA

  • Treatment

    Alternative therapy, SOC

  • Trial Participants

    140

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    NA

  • Treatment

    Other, SOC

  • Trial Participants

    480

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    Cough, C-Reactive Protein, IgG, IgM or IgA

  • Treatment

    Alternative therapy, SOC

  • Trial Participants

    60

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    NA

  • Treatment

    Ivermectin, SOC

  • Trial Participants

    50

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    NA

  • Treatment

    Ivermectin, SOC

  • Trial Participants

    50

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    Cough, Fever, Dyspnea

  • Treatment

    Alternative therapy, SOC

  • Trial Participants

    30

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    Viral Load or Clearance

  • Treatment

    Alternative therapy, Vitamins + Zinc

  • Trial Participants

    50

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    Clinical Improvement Score (Any)

  • Treatment

    Alternative therapy

  • Trial Participants

    20

New Delhi
  • COVID-19 status

    Confirmed Or Suspected

  • Outcome

    Cough

  • Treatment

    Alternative therapy, SOC

  • Trial Participants

    120

New Delhi
  • COVID-19 status

    Healthy, Confirmed

  • Outcome

    Mortality, Hospital Discharge, Pneumonia or ARDS, Distress

  • Treatment

    HCQ, HCQ + LPV/r, LPV/r, SOC

  • Trial Participants

    6400

New Delhi
  • COVID-19 status

    Unclear

  • Outcome

    Mortality, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA)

  • Treatment

    ARBs, SOC

  • Trial Participants

    186

New Delhi
  • COVID-19 status

    NA

  • Outcome

    Hospitalization, Invasive Mechanical Ventilation or ECMO, Adverse Events, Heart Rate

  • Treatment

    HCQ, SOC

  • Trial Participants

    32

New Delhi
  • COVID-19 status

    Healthy, Suspected

  • Outcome

    NA

  • Treatment

    Other + Vitamins + Alternative therapy + Nutrition, SOC

  • Trial Participants

    110

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    NA

  • Treatment

    Other, SOC

  • Trial Participants

    100

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    NA

  • Treatment

    Alternative therapy, SOC

  • Trial Participants

    116

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    ICU Admission

  • Treatment

    Alternative therapy

  • Trial Participants

    100

New Delhi
  • COVID-19 status

    Confirmed

  • Outcome

    NA

  • Treatment

    Other, SOC

  • Trial Participants

    48

New Delhi
  • COVID-19 status

    Suspected

  • Outcome

    NA

  • Treatment

    Alternative therapy, SOC

  • Trial Participants

    300

New Delhi
  • COVID-19 status

    Healthy

  • Outcome

    NA

  • Treatment

    Alternative therapy, SOC

  • Trial Participants

    21500

New Delhi
  • COVID-19 status

    Healthy

  • Outcome

    Mortality

  • Treatment

    Alternative therapy, SOC

  • Trial Participants

    1000

New Delhi
  • COVID-19 status

    Healthy

  • Outcome

    NA

  • Treatment

    Alternative therapy, SOC

  • Trial Participants

    5000

New Delhi
  • COVID-19 status

    Healthy

  • Outcome

    NA

  • Treatment

    Alternative therapy, SOC

  • Trial Participants

    5000

New Delhi
  • COVID-19 status

    Healthy

  • Outcome

    NA

  • Treatment

    Alternative therapy, SOC

  • Trial Participants

    500

New Delhi
  • COVID-19 status

    Healthy

  • Outcome

    NA

  • Treatment

    Alternative therapy, SOC

  • Trial Participants

    800

New Delhi
  • COVID-19 status

    Healthy

  • Outcome

    NA

  • Treatment

    Other + Vitamins

  • Trial Participants

    500

New Delhi
  • COVID-19 status

    Healthy

  • Outcome

    NA

  • Treatment

    HCQ

  • Trial Participants

    400

New Delhi
  • COVID-19 status

    Suspected

  • Outcome

    Cough, Fever, Dyspnea

  • Treatment

    Other, SOC

  • Trial Participants

    30

New Delhi
  • COVID-19 status

    Healthy (Exposed)

  • Outcome

    Cough, Other Mild Symptoms

  • Treatment

    Alternative therapy

  • Trial Participants

    50

New Delhi
  • COVID-19 status

    Healthy

  • Outcome

    NA

  • Treatment

    Alternative therapy, SOC

  • Trial Participants

    60

New Delhi
  • COVID-19 status

    Healthy

  • Outcome

    NA

  • Treatment

    Alternative therapy, SOC

  • Trial Participants

    800

New Delhi
  • COVID-19 status

    Healthy

  • Outcome

    Cough, Fever, Dyspnea

  • Treatment

    Alternative therapy, SOC

  • Trial Participants

    30

New Delhi
  • COVID-19 status

    Healthy

  • Outcome

    NA

  • Treatment

    Alternative therapy, SOC

  • Trial Participants

    5000

New Delhi
  • COVID-19 status

    Healthy

  • Outcome

    NA

  • Treatment

    Alternative therapy, SOC

  • Trial Participants

    33000

New Delhi
  • COVID-19 status

    Healthy

  • Outcome

    NA

  • Treatment

    Alternative therapy, SOC

  • Trial Participants

    5000

New Delhi
  • COVID-19 status

    Healthy

  • Outcome

    NA

  • Treatment

    Other, SOC

  • Trial Participants

    4000

New Delhi
  • COVID-19 status

    Healthy

  • Outcome

    NA

  • Treatment

    Exercise + Alternative therapy, SOC

  • Trial Participants

    604

New Delhi
  • COVID-19 status

    Healthy

  • Outcome

    NA

  • Treatment

    Alternative therapy

  • Trial Participants

    40000

New Delhi
  • COVID-19 status

    Healthy

  • Outcome

    NA

  • Treatment

    Alternative therapy

  • Trial Participants

    275

New Delhi
  • COVID-19 status

    Healthy

  • Outcome

    NA

  • Treatment

    Alternative therapy, SOC

  • Trial Participants

    5000

New Delhi
  • COVID-19 status

    Healthy

  • Outcome

    NA

  • Treatment

    Alternative therapy

  • Trial Participants

    4000

New Delhi
  • COVID-19 status

    Healthy

  • Outcome

    NA

  • Treatment

    Alternative therapy

  • Trial Participants

    1500

New Delhi
  • COVID-19 status

    Healthy

  • Outcome

    Viral Load or Clearance

  • Treatment

    Hygiene

  • Trial Participants

    204

New Delhi
  • COVID-19 status

    NA

  • Outcome

    Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea

  • Treatment

    Alternative therapy

  • Trial Participants

    30

New Delhi
  • COVID-19 status

    Healthy

  • Outcome

    NA

  • Treatment

    Alternative therapy, SOC

  • Trial Participants

    600

New Delhi
  • COVID-19 status

    Healthy

  • Outcome

    Serious Adverse Events, Antibodies

  • Treatment

    SOC, Vaccine

  • Trial Participants

    1125

New Delhi
  • COVID-19 status

    Healthy

  • Outcome

    C-Reactive Protein

  • Treatment

    Melatonin, SOC

  • Trial Participants

    200

New Delhi
  • COVID-19 status

    Healthy

  • Outcome

    NA

  • Treatment

    Alternative therapy

  • Trial Participants

    10

New Delhi
  • COVID-19 status

    Healthy

  • Outcome

    C-Reactive Protein, Ferritin, Troponin, LDH

  • Treatment

    Alternative therapy

  • Trial Participants

    10

Odisha
  • COVID-19 status

    Healthy

  • Outcome

    Serious Adverse Events, Antibodies

  • Treatment

    SOC, Vaccine

  • Trial Participants

    1125

Punjab
  • COVID-19 status

    Healthy

  • Outcome

    NA

  • Treatment

    Alternative therapy

  • Trial Participants

    50

Rajasthan
  • COVID-19 status

    Healthy

  • Outcome

    NA

  • Treatment

    Alternative therapy

  • Trial Participants

    500

Rajasthan
  • COVID-19 status

    Suspected

  • Outcome

    Viral Load or Clearance

  • Treatment

    Alternative therapy

  • Trial Participants

    40

Rajasthan
  • COVID-19 status

    Healthy

  • Outcome

    NA

  • Treatment

    Alternative therapy

  • Trial Participants

    50

Rajasthan
  • COVID-19 status

    Healthy

  • Outcome

    NA

  • Treatment

    Alternative therapy

  • Trial Participants

    12000

Uttar Pradesh
  • COVID-19 status

    Confirmed

  • Outcome

    NA

  • Treatment

    Alternative therapy, SOC

  • Trial Participants

    60

Uttar Pradesh
  • COVID-19 status

    Healthy

  • Outcome

    Serious Adverse Events, Antibodies

  • Treatment

    SOC, Vaccine

  • Trial Participants

    1125

State COVID-19 status Outcome Treatment Trial Participants
Andhra Pradesh Healthy Serious Adverse Events, Antibodies SOC, Vaccine 1125
Bihar Healthy Serious Adverse Events, Antibodies SOC, Vaccine 1125
Chandigarh Confirmed Mortality, Hospitalization, Clinical Improvement Score (Any), Non-invasive Ventilation, Organ Failure or Dysfunction (SOFA) Other, SOC 40
Chandigarh NA ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Other Mild Symptoms, Adverse Events, Serious Adverse Events Other, SOC 480
Chandigarh Healthy NA HCQ, SOC 325
Chandigarh NA Serious or Seconday Infections, Adverse Events, Serious Adverse Events Other 4000
Chhattisgarh Confirmed Mortality, Hospitalization, Clinical Improvement Score (Any), Non-invasive Ventilation, Organ Failure or Dysfunction (SOFA) Other, SOC 40
Delhi Confirmed Or Suspected Hospital Discharge, Invasive Mechanical Ventilation or ECMO Positioning 20
Delhi Healthy NA Alternative therapy, SOC 140
Delhi Healthy NA Alternative therapy, SOC 50000
Delhi Confirmed ICU Admission, Hospital Discharge, Clinical Improvement Score (Any) Plasma based therapy, SOC 400
Delhi Confirmed Mortality Alternative therapy, SOC 100
Delhi Confirmed NA Radiation therapy 10
Delhi Confirmed NA Alternative therapy 50
Delhi Confirmed Mortality, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Fever, Dyspnea, Other Mild Symptoms, Organ Failure or Dysfunction (SOFA), Adverse Events, PaO2-FiO2 Plasma based therapy, SOC 100
Delhi Yes Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), PaO2-FiO2 Plasma based therapy, SOC 29
Delhi Confirmed Viral Load or Clearance Ivermectin, SOC 50
Delhi Confirmed Mortality, Pneumonia or ARDS, PaO2-FiO2 Plasma based therapy, SOC 452
Delhi Confirmed Mortality, Hospitalization, Clinical Improvement Score (Any), Non-invasive Ventilation, Organ Failure or Dysfunction (SOFA) Other, SOC 40
Delhi Confirmed Mortality, Pneumonia or ARDS, PaO2-FiO2 Plasma based therapy, SOC 100
Delhi Confirmed Mortality Alternative therapy, SOC 300
Delhi Confirmed NA Alternative therapy 40
Delhi Healthy NA Alternative therapy, SOC 200
Delhi Suspected NA Alternative therapy 10000
Delhi Healthy NA Alternative therapy, SOC 40000
Delhi Healthy NA Exercise + Alternative therapy, SOC 452
Delhi Healthy Serious Adverse Events, Antibodies SOC, Vaccine 1125
Goa Healthy Serious Adverse Events, Antibodies SOC, Vaccine 1125
Gujarat Confirmed Mortality, Clinical Improvement Score (Any) Alternative therapy, SOC 200
Gujarat Confirmed Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, C-Reactive Protein, Ferritin, IL-6, IL-10, Tumor Necrosis Factor (Any) Other, SOC 100
Haryana Confirmed Hospital Discharge Alternative therapy, SOC 60
Haryana Confirmed Mortality SOC, TCZ 180
Haryana Healthy Serious Adverse Events, Antibodies SOC, Vaccine 1125
Karnataka Confirmed Viral Load or Clearance, Pneumonia or ARDS, Cough, Fever, Organ Failure or Dysfunction (SOFA), Antibodies, PaO2-FiO2, SpO2, Radiographic Findings, Distress, Renal Outcome (Unspecified) Plasma based therapy, SOC 24
Karnataka Healthy Serious Adverse Events, Antibodies SOC, Vaccine 1125
Madhya Pradesh Confirmed Mortality, Hospitalization, Clinical Improvement Score (Any), Non-invasive Ventilation, Organ Failure or Dysfunction (SOFA) Other, SOC 40
Maharashtra Confirmed Hospitalization, Viral Load or Clearance, Cough, Fever, Other Mild Symptoms, Platelet Count Alternative therapy, SOC 15
Maharashtra Confirmed NA FPV, SOC 156
Maharashtra Confirmed Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, C-Reactive Protein, Ferritin, IL-6, IL-10, Tumor Necrosis Factor (Any) Other, SOC 100
New Delhi Healthy NA SOC, Vaccine 1048
New Delhi Healthy Mortality SOC, Vaccine 2175
New Delhi Healthy Cough, Other Mild Symptoms Ivermectin 50
New Delhi Confirmed NA Alternative therapy 30
New Delhi Confirmed NA Alternative therapy 200
New Delhi Confirmed Viral Load or Clearance Alternative therapy 60
New Delhi Confirmed ICU Admission, Hospital Discharge SOC, Zinc 100
New Delhi Confirmed NA Alternative therapy 124
New Delhi Confirmed NA SOC, Vitamins 30
New Delhi Confirmed ICU Admission Alternative therapy, SOC 36
New Delhi Confirmed Mortality mAb, SOC 30
New Delhi Confirmed Clinical Improvement Score (Any) Anticoagulants, SOC 40
New Delhi Healthy, Confirmed Hospital Discharge Alternative therapy, SOC 120
New Delhi Confirmed C-Reactive Protein, Ferritin, LDH, SpO2, Radiographic Findings Non-invasive respiratory support, SOC 60
New Delhi Confirmed NA Alternative therapy, SOC 140
New Delhi Confirmed Clinical Improvement Score (Any) Alternative therapy, AZT + Vitamins + Other 25
New Delhi Confirmed Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), SpO2, Shock, Distress Alternative therapy, SOC 200
New Delhi Confirmed NA Alternative therapy, HCQ 100
New Delhi Confirmed Fever Alternative therapy, SOC 30
New Delhi Confirmed Viral Load or Clearance Ivermectin, SOC 50
New Delhi Healthy, Confirmed Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious or Seconday Infections, Serious Adverse Events, ALT HCQ, LPV/r, SOC 6400
New Delhi NA Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Other Mild Symptoms HCQ 500
New Delhi Healthy (Exposed) Cough, Fever, Dyspnea, Antibodies, Distress SOC, Vaccine 1826
New Delhi Healthy NA Alternative therapy 1324
New Delhi Healthy NA Alternative therapy, SOC 1200
New Delhi Healthy NA Alternative therapy, SOC 1200
New Delhi Healthy (Exposed) NA HCQ, SOC 6950
New Delhi Healthy NA SOC, Vaccine 5946
New Delhi Healthy NA Alternative therapy, SOC 1200
New Delhi Confirmed Mortality, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO HCQ, HCQ + AZT 300
New Delhi Confirmed NA HCQ, SOC 60
New Delhi Confirmed ICU Admission, Hospital Discharge, Clinical Improvement Score (Any) Plasma based therapy, SOC 400
New Delhi Confirmed NA HCQ, SOC 166
New Delhi Confirmed Hospital Discharge, Clinical Improvement Score (Any) Other 50
New Delhi Confirmed NA Alternative therapy, SOC 300
New Delhi Confirmed Hospital Discharge, Viral Load or Clearance HCQ, HCQ + Antivirals 158
New Delhi Confirmed NA Corticosteroids, HCQ, Ivermectin, SOC 120
New Delhi Confirmed NA Alternative therapy, SOC 120
New Delhi Confirmed Viral Load or Clearance Alternative therapy, SOC 60
New Delhi Confirmed Invasive Mechanical Ventilation or ECMO Plasma based therapy, SOC 40
New Delhi Confirmed Viral Load or Clearance Hygiene, SOC 96
New Delhi Confirmed Or Suspected Mortality Alternative therapy 100
New Delhi Confirmed Cough, Fever, SpO2, Respiratory Rate HCQ + Antivirals, LPV/r + antivirals 175
New Delhi Confirmed Quality of Life Alternative therapy, SOC 120
New Delhi Confirmed NA Alternative therapy, SOC 90
New Delhi Confirmed NA Alternative therapy, HCQ + Vitamins + AZT + Zinc + Other 200
New Delhi Confirmed NA Other, SOC 300
New Delhi Confirmed Viral Load or Clearance Alternative therapy, SOC 60
New Delhi Confirmed Hospitalization Alternative therapy, SOC 420
New Delhi Confirmed IL-6 Alternative therapy, SOC 10
New Delhi Confirmed NA Alternative therapy, SOC 90
New Delhi Confirmed NA Alternative therapy, SOC 200
New Delhi Confirmed Mortality, Hospital Discharge, Clinical Improvement Score (Any) Alternative therapy, SOC 100
New Delhi Confirmed NA IFN, SOC 40
New Delhi Confirmed Pneumonia or ARDS Exercise + Nutrition + Hygiene + Alternative therapy + Other, SOC 658
New Delhi Confirmed Viral Load or Clearance, Cough, Fever, IL-2, IL-6, IL-10, Tumor Necrosis Factor (Any), IgG, IgM or IgA Alternative therapy, Vitamins + Zinc 60
New Delhi Confirmed NA Alternative therapy 40
New Delhi Confirmed Mortality, ICU Admission, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO Alternative therapy 40
New Delhi Confirmed NA Alternative therapy 200
New Delhi Confirmed NA Alternative therapy 200
New Delhi Confirmed NA Exercise + Alternative therapy 30
New Delhi Confirmed Or Suspected NA Alternative therapy, SOC 80
New Delhi Confirmed Or Suspected NA Alternative therapy, SOC 86
New Delhi Healthy NA Alternative therapy, SOC 60
New Delhi Healthy Mortality Vaccine 1450
New Delhi Suspected Anxiety Psychological therapy 128
New Delhi Confirmed Mortality HCQ +/- AZT, HCQ + Lithium +/- AZT 100
New Delhi Confirmed ICU Admission, Organ Failure or Dysfunction (SOFA) SOC, Vaccine 40
New Delhi Healthy, Confirmed Or Suspected Clinical Improvement Score (Any), Quality of Life Alternative therapy, SOC 500
New Delhi Confirmed NA Alternative therapy 150
New Delhi Confirmed Mortality DAA 50
New Delhi Confirmed NA Alternative therapy 100
New Delhi Confirmed ICU Admission, Invasive Mechanical Ventilation or ECMO Non-invasive respiratory support, SOC 40
New Delhi Confirmed Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO Other, SOC 300
New Delhi Confirmed Mortality, ICU Admission, Hospitalization Radiation therapy 10
New Delhi Confirmed NA Alternative therapy, SOC 112
New Delhi Confirmed Mortality, Hospital Discharge, Clinical Improvement Score (Any), Labor Absenteeism, Fever, SpO2, Respiratory Rate Other, SOC 230
New Delhi Confirmed NA Imatinib, SOC 100
New Delhi Confirmed Cough, Fever, Dyspnea, Other Mild Symptoms Alternative therapy 60
New Delhi Confirmed C-Reactive Protein Other, SOC 100
New Delhi Confirmed Mortality, Hospital Discharge Plasma based therapy, SOC 80
New Delhi Confirmed Mortality, Clinical Improvement Score (Any) Plasma based therapy, SOC 472
New Delhi Confirmed Mortality, Pneumonia or ARDS, PaO2-FiO2 Plasma based therapy, SOC 90
New Delhi Confirmed Mortality, Organ Failure or Dysfunction (SOFA) Plasma based therapy, SOC 100
New Delhi Confirmed Mortality, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, SpO2 Positioning 120
New Delhi Confirmed Hospitalization Acalabrutinib, SOC 30
New Delhi Confirmed Invasive Mechanical Ventilation or ECMO Acalabrutinib, SOC 140
New Delhi Confirmed Pneumonia or ARDS Plasma based therapy, SOC 20
New Delhi Confirmed Hospital Discharge, Clinical Improvement Score (Any) Igs, SOC 100
New Delhi Confirmed Hospital Discharge, Cough, Fever, Dyspnea Alternative therapy, SOC 120
New Delhi Confirmed Mortality mAb, SOC 30
New Delhi Confirmed NA FPV, SOC 150
New Delhi Confirmed NA Alternative therapy 135
New Delhi Confirmed Clinical Improvement Score (Any) Alternative therapy, SOC 200
New Delhi Confirmed Hospital Discharge, Clinical Improvement Score (Any) Alternative therapy, SOC 160
New Delhi Confirmed Clinical Improvement Score (Any) FPV, FPV + Umifenovir 158
New Delhi Confirmed Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO Other, SOC 300
New Delhi Confirmed Hospitalization, Hospital Discharge, Distress SOC, Vaccine 60
New Delhi Confirmed Invasive Mechanical Ventilation or ECMO, PaO2-FiO2 HCQ + AZT, HCQ + Other + AZT 120
New Delhi Confirmed Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO HCQ, LPV/r, Remdesivir, SOC 7000
New Delhi Confirmed NA HCQ, LPV/r, LPV/r + IFN, Remdesivir, SOC 10000
New Delhi Confirmed ICU Admission, Hospitalization, C-Reactive Protein Other + Vitamins 210
New Delhi Confirmed NA Alternative therapy, SOC 120
New Delhi Confirmed Cough, C-Reactive Protein, IgG, IgM or IgA, CD4, CD8 Alternative therapy, SOC 60
New Delhi Confirmed NA Alternative therapy, SOC 140
New Delhi Confirmed NA Other, SOC 480
New Delhi Confirmed Cough, C-Reactive Protein, IgG, IgM or IgA Alternative therapy, SOC 60
New Delhi Confirmed NA Ivermectin, SOC 50
New Delhi Confirmed NA Ivermectin, SOC 50
New Delhi Confirmed Cough, Fever, Dyspnea Alternative therapy, SOC 30
New Delhi Confirmed Viral Load or Clearance Alternative therapy, Vitamins + Zinc 50
New Delhi Confirmed Clinical Improvement Score (Any) Alternative therapy 20
New Delhi Confirmed Or Suspected Cough Alternative therapy, SOC 120
New Delhi Healthy, Confirmed Mortality, Hospital Discharge, Pneumonia or ARDS, Distress HCQ, HCQ + LPV/r, LPV/r, SOC 6400
New Delhi Unclear Mortality, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA) ARBs, SOC 186
New Delhi NA Hospitalization, Invasive Mechanical Ventilation or ECMO, Adverse Events, Heart Rate HCQ, SOC 32
New Delhi Healthy, Suspected NA Other + Vitamins + Alternative therapy + Nutrition, SOC 110
New Delhi Confirmed NA Other, SOC 100
New Delhi Confirmed NA Alternative therapy, SOC 116
New Delhi Confirmed ICU Admission Alternative therapy 100
New Delhi Confirmed NA Other, SOC 48
New Delhi Suspected NA Alternative therapy, SOC 300
New Delhi Healthy NA Alternative therapy, SOC 21500
New Delhi Healthy Mortality Alternative therapy, SOC 1000
New Delhi Healthy NA Alternative therapy, SOC 5000
New Delhi Healthy NA Alternative therapy, SOC 5000
New Delhi Healthy NA Alternative therapy, SOC 500
New Delhi Healthy NA Alternative therapy, SOC 800
New Delhi Healthy NA Other + Vitamins 500
New Delhi Healthy NA HCQ 400
New Delhi Suspected Cough, Fever, Dyspnea Other, SOC 30
New Delhi Healthy (Exposed) Cough, Other Mild Symptoms Alternative therapy 50
New Delhi Healthy NA Alternative therapy, SOC 60
New Delhi Healthy NA Alternative therapy, SOC 800
New Delhi Healthy Cough, Fever, Dyspnea Alternative therapy, SOC 30
New Delhi Healthy NA Alternative therapy, SOC 5000
New Delhi Healthy NA Alternative therapy, SOC 33000
New Delhi Healthy NA Alternative therapy, SOC 5000
New Delhi Healthy NA Other, SOC 4000
New Delhi Healthy NA Exercise + Alternative therapy, SOC 604
New Delhi Healthy NA Alternative therapy 40000
New Delhi Healthy NA Alternative therapy 275
New Delhi Healthy NA Alternative therapy, SOC 5000
New Delhi Healthy NA Alternative therapy 4000
New Delhi Healthy NA Alternative therapy 1500
New Delhi Healthy Viral Load or Clearance Hygiene 204
New Delhi NA Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea Alternative therapy 30
New Delhi Healthy NA Alternative therapy, SOC 600
New Delhi Healthy Serious Adverse Events, Antibodies SOC, Vaccine 1125
New Delhi Healthy C-Reactive Protein Melatonin, SOC 200
New Delhi Healthy NA Alternative therapy 10
New Delhi Healthy C-Reactive Protein, Ferritin, Troponin, LDH Alternative therapy 10
Odisha Healthy Serious Adverse Events, Antibodies SOC, Vaccine 1125
Punjab Healthy NA Alternative therapy 50
Rajasthan Healthy NA Alternative therapy 500
Rajasthan Suspected Viral Load or Clearance Alternative therapy 40
Rajasthan Healthy NA Alternative therapy 50
Rajasthan Healthy NA Alternative therapy 12000
Uttar Pradesh Confirmed NA Alternative therapy, SOC 60
Uttar Pradesh Healthy Serious Adverse Events, Antibodies SOC, Vaccine 1125

Ongoing Research on COVID-19 Treatments & Vaccines (Global)

From drug developers to academic labs, communities worldwide have joined hands to develop
different kinds of vaccines & medical products to combat the spread of COVID-19.

Antibodies

Antibodies

80

Antivirals

Antivirals

31

Cell-Based Therapy

Cell-Based Therapy

35

Device

Device

10

DNA - Based

DNA - Based

16

Inactivated Virus

Inactivated Virus

14

Live Attenuated Virus

Live Attenuated Virus

4

Non-Replicating Viral Vector

Non-Replicating Viral Vector

25

Protein Subunit

Protein Subunit

70

Replicating Bacterial Vector

Replicating Bacterial Vector

2

Replicating viral vector

Replicating viral vector

18

RNA- Based Treatments

RNA- Based Treatments

6

RNA- Based Vaccine

RNA- Based Vaccine

27

Scanning Compounds to Repurpose

Scanning Compounds to Repurpose

21

Virus Like Particle

Virus Like Particle

16

Others

Others

152

Vaccines in News

Disclaimer

CoVaTrack aggregates publicly available information on progress of CoVID-19 related vaccines & treatment. CoVaTrack's sources for data include official websites of Centre for Disease Control & Prevention (CDC), World Health Organisation (WHO), Milken Institute, Cytel and New York Times. Utmost care is taken to rely on credible data sources. No liability exists for any inaccuracies reflecting in the data itself.

  • The Center for Disease Control and Prevention (CDC)
  • The World Health Organization (WHO)
  • Cytel's Covid Trials
  • Milken Institute
  • New York Times Coronavirus Vaccine